Condition: Respiratory Distress Syndrome of Newborn · Threatened Premature Labor, Antepartum · Sponsor: Dongyang Liu
This study through to the pregnant woman blood concentrations of dexamethasone therapy after research, explore the pharmacokinetic data of dexamethasone in pregnant women, Chinese pregnant women dexamethasone pharmacokinetic model, provide a reference for the clinical use of dexamethasone dose, through the biomarkers of dexamethasone to promote fetal lung maturity and other metabolomics, It provides the basis for the effectiveness and safety study of dexamethasone.
This description comes directly from the study's public registry record.
Dongyang Liu · （86）010-82266658 · liudongyang@vip.sina.com
Song Jie · 86-17302556737 · fssongjie@163.com
Always discuss trial participation with your own doctor first.
| Dongyang Liu | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05207852